Heron Therapeutics News: HRTX Stock Tanks on FDA Rejection

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Heron Therapeutics news concerning the company's HTX-011 pain drug and an FDA letter has HRTX stock falling hard on Wednesday.

The post Heron Therapeutics News: HRTX Stock Tanks on FDA Rejection appeared first on InvestorPlace.

• 7 A-Rated Stocks That Are Under $10
• 7 Stocks That Are Soaring This Earnings Season
• 5 Biotech Stocks for a Long-Lived Portfolio
• 10 Times Apple's Hardware Failed Consumers -- And Hurt Its Business